Dr. Roxana Mehran, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: medicines company(MODEST), Medscape(MODEST), Abbott Vascular(MODEST), Abiomed(MODEST), Roivant Sciences(MODEST), Spectranetics(MODEST) RESEARCH/RESEARCH GRANTS: AstraZeneca(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), CSL Behring (SIGNIFICANT), Novartis Pharmaceuticals(SIGNIFICANT), Medtronic(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), Boston Scientific(SIGNIFICANT), OrbusNeich(SIGNIFICANT) OTHER FINANCIAL BENEFIT: WebMD(MODEST), Wiley Blackwell Publishing Company(MODEST), Janssen Pharmaceuticals, Inc(MODEST), Osprey Medical(MODEST), Bristol-Myers Squibb Company (MODEST), Elixir Medical(NONE), Claret Medical(SIGNIFICANT)

View Full Disclosure